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Abstract
Background: Lately, ontologies have become a fundamental building block in the process of formalising and storing
complex biomedical information. The community-driven ontology curation process, however, ignores the possibility
of multiple communities building, in parallel, conceptualisations of the same domain, and thus providing slightly
different perspectives on the same knowledge. The individual nature of this effort leads to the need of a mechanism
to enable us to create an overarching and comprehensive overview of the different perspectives on the domain
knowledge.
Results: We introduce an approach that enables the loose integration of knowledge emerging from diverse sources
under a single coherent interoperable resource. To accurately track the original knowledge statements, we record the
provenance at very granular levels. We exemplify the approach in the rare bone disorders domain by proposing the
Rare Bone Disorders Ontology (RBDO). Using RBDO, researchers are able to answer queries, such as: “What phenotypes
describe a particular disorder and are common to all sources?” or to understand similarities between disorders based on
divergent groupings (classifications) provided by the underlying sources.
Availability: RBDO is available at http://purl.org/skeletome/rbdo. In order to support lightweight query and
integration, the knowledge captured by RBDO has also been made available as a SPARQL Endpoint at http://bio-lark.
org/se_skeldys.html.
Multiple perspectives over the same domain
Ontologies represent a formalised description of the con-
cepts and relationships in a domain. For example, they can
be used to model and capture knowledge around a par-
ticular set of hereditary disorders (e.g., bone dysplasias),
in addition to their underlying genetic mechanisms (relat-
ing disorders to genes) and their observable traits (relating
disorders to phenotypes). Over the course of the past
decade, they have become one of the main mechanisms
used in building intelligent systems and algorithms to sup-
port, among others, the study of cross-species phenotype
networks [1-3], gene screening, prediction and prioritiza-
tion [1,4] or disorder prediction [5,6]. This rising adop-
tion, in particular by the biomedical community, has led
to the proliferation of the number of ontologies published
openly via repositories such as the NCBO BioPortal [7]
or the Open Biological and Biomedical Ontology (OBO)
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Foundry [8]. An effect of this uptake has been the need for
a community-driven process [9], which requires a shared
understanding of the rules and primitives that govern the
domain under scrutiny. More concretely, experts required
appropriate mechanisms to update and evolve ontologies
and the domain knowledge, in order to ensure an accurate
knowledge transfer. A relevant example of such collab-
orative knowledge curation is the development of the
International Classification of Disorders (ICD-11) [10], or
efforts like the Gene Ontology [11], the Human Pheno-
type Ontology [12] or the International Classification for
Nursing Practice (ICNP) [13].
Recognising the need for community-oriented knowl-
edge curation does not, however, take into account that
multiple communities may target, in parallel, the concep-
tualisation of the same domain. This, in turn, leads to
ontologies that provide slightly different perspectives on
the same knowledge. These perspectives differ in:
1. focus – the particular aspects of the domain – e.g.,
given a particular set of disorders, a community may
© 2015 Groza et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative Commons
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focus more on the genetic mechanisms, while
another one on the clinical presentation,
2. granularity – the level of detail considered in the
knowledge modelling process – e.g., given the same
context, the knowledge captured by a community
may include the prevalence of the disorders or the
age of onset, while in other cases this knowledge may
be omitted, or
3. in the underlying interests or priorities of those
creating them – for example, a community may just
be interested in the clinical presentation of the
disorders because of its focus on clinical diagnosis.
We are currently missing a key mechanism to allow
us to create a comprehensive overview of the different
perspectives on the domain knowledge.
Ontology integration is a field that has been extensively
studied in the past. Although several definitions of “ontol-
ogy integration” exist in the literature [14], it is usually
referred (as is in our case) to the process of combining two
or more ontologies about the same subject into a single
unified ontology. One step in the integration process is to
find the correspondences (a.k.a., mappings) between the
semantically-related entities, which can be done manu-
ally or (semi-automatically). The ontology-matching topic
that has seen an enormous amount of research, as shown
by several comprehensive and thorough surveys that are
available in the literature [15-18]. All these approaches
are focused on trying to identify in a (semi-)automatic
manner the correspondences between entities in differ-
ent ontologies. This is not the focus of our work, as the
mappings between the two resources were identified in a
manual fashion by a domain expert. Even more, existing
work on ontology integration does not keep track of the
provenance of the integrated entities. This novel aspect of
our work brings several benefits, which are discussed later
in the paper.
In the biomedical domain, many ontologies create
cross-references to other vocabularies, as a means to
keeping track of both the mapping between terms, and,
sometimes, provenance of a term. The UMLS Metathe-
saurus [19] provides the Concept Unique Identifiers (CUI)
that represent the unique meaning of a concept and is
used to map between terms from different source vocabu-
laries. The Disease Ontology (DO) [20] reuses terms from
different biomedical ontologies (MeSH, ICD, OMIM and
NCI Thesaurus), either by inclusion or cross-mapping,
and keeps track of their provenance by recording their
source id as a property associated to the class. As such,
the Disease Ontology provides a rich resource for seman-
tically connecting phenotypic, gene and genetic informa-
tion related to human disease. Even though, the Disease
Ontology approach is somewhat related to ours, there are
two significant differences: (i) The domains covered by the
DO and our RBDO are different (general disease vs. rare
bone disorders); (ii) Our focus is on storing the prove-
nance at very granular level, including at the relationship
level (as opposed to only at entity level), in a manner that
is computable.
In this paper we present a model, and its associated
implementation, aimed at integrating classifications of
disorders developed by multiple entities, with a focus
on the rare bone disorder domain. More concretely, we
showcase the integration of the ORPHANET rare bone
disorders classification [21] with the International Skele-
tal Dysplasia Society Nosology [22]. The resulting ontol-
ogy – the Rare Bone Disorders Ontology – structures
knowledge via the Simple Knowledge Organisation Sys-
tem (SKOS) vocabulary [23] and documents provenance
via the Provenance Ontology [24]. From a conceptual per-
spective, the atomic elements of the classification integra-
tion resemble nano-publications [25], while RBDO acts as
a coherent aggregation of such nano-publications. Finally,
we describe a simple SPARQL query interface that enables
the interaction with the knowledge, directly via SPARQL
queries or via pre-built query templates.
Current status in the rare bone disorders domain
Rare bone diseases knowledge resources
The rare bone disorders domain is an example where the
above-mentioned integration challenge can be observed
and where developing a consolidated solution would ben-
efit the all communities working on the topic. In this
section, we discuss the existing domain knowledge repre-
sentations together with their advantages and shortcom-
ings.
The International Skeletal Dysplasia Society (ISDS)
publishes every 4 years the Nosology of bone dys-
plasias [22] – based on the recommendation provided
by a panel of experts. The Nosology classifies each dis-
order into a single group, based either on its clinical
radiographic appearance or on its underlying molecu-
lar genetic mechanism. In some cases, this classification
scheme proves to be too rigid, since disorders may easily
be associated withmultiple groups – due also to the lack of
a complete overview of the knowledge surrounding them.
Furthermore, the actual Nosology incorporates only the
genotype of the domain, with no relationships to the char-
acteristic phenotypes (which are implicitly present in the
taxonomy).
The Bone Dysplasia Ontology (BDO) [26] aims to
address some of the shortcomings of the Nosology by
transforming it into an appropriate knowledge represen-
tation formalism. BDO maintains the taxonomical organ-
isation of the Nosology and the genotype description
but also includes disorder – phenotype associations com-
piled from the clinical synopses published in the Online
Mendelian Inheritance in Man database (OMIM) [27].
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More concretely, the authors annotate the clinical syn-
opses with Human Phenotype Ontology (HPO) [12] con-
cepts and link the resulting annotations to skeletal dys-
plasias in BDO. Overall, the Bone Dysplasia ontology acts
as a consolidating agent between the ISDS Nosology and
the OMIM phenotype description of the disorders.
TheOrphanet Consortium, on the other hand, has also
developed over the years a taxonomy of rare bone disor-
ders that lists skeletal dysplasias as central elements. This
taxonomy, more elaborated than the ISDS Nosology, is
enriched with manually curated genotype and phenotype
knowledge, the latter including an additional level of detail
and mappings to HPO concepts (i.e., the degree of occur-
rence of the phenotype in the context of the disorder -
e.g., Achondroplasia is associated “very frequently” to
Macrocephaly).
Differences in the representation of the current resources
There are several major differences between the
BDO/ISDS and Orphanet that are worth noting. As a
side note, we need to remark that the Orphanet classifi-
cation is by default more generic and includes disorders
that are not bone dysplasias. Our analysis, however,
focuses strictly on those components of Orphanet that
are common to both classifications.
1. Orphanet introduces a more fine-grained pheno-
typic annotation by specifying the frequency of occur-



















Class: Multiple epiphyseal dysplasia,
Al-Gazali type
Annotations:





2. The Orphanet taxonomy is more complex, nesting






































Class: Abnormal mineralization group
SubClassOf: Bone Dysplasia
Class: Hypophosphatasia adult form
SubClassOf: Abnormal mineralization group
3. The disorder classification mechanism also differs.
Orphanet uses the hierarchy to denote both grouping of
disorders, e.g., several disorders are part of the FGFR3
Chondrodysplasia Group, as well as sub-typing,
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e.g., Mesomelic dysplasia, Korean type is
(conceptually) a type of Mesomelic dysplasia. Such













































... Class: Hypophosphatasia adult form




4. The number of bone dysplasias and their pheno-
type associations covered by the two sources differs
significantly: (i) there are 202 bone dysplasias present
in BDO but not in Orphanet (i.e., 38.5% of the total of
524 disorders listed in BDO); (ii) BDO reuses 2,183 HPO
concepts to describe phenotypic characteristics, while
Orphanet reuses only 1,133 HPO concepts.
5. The actual disorder – phenotype associations are
different between BDO and Orphanet. For example,
Adams-Oliver syndrome has 40 HPO concepts asso-
ciated in BDO and 66 in Orphanet, only 14 of which are in
common.
Both classification systems have been developed by
domain experts and the apparent differences might reflect
true differences in opinion between the expert groups.We
do not suggest that this divergence is due to errors and
that a ground truth should exist, as there is no easy way
to reconcile them to arrive at such a ground truth. We
do, however, advocate for building a model that is able to
represent both classifications by recording the appropri-
ate provenance and that enables researchers to use both
sources in an integrated or comparative manner.
In the remainder of the paper we discuss the benefits
of integrating diverse domain knowledge views and then
propose a new ontology, named the Rare Bone Disorders
Ontology (RBDO), which shows how to achieve this inte-
gration from a pragmatic perspective. The goal of RBDO
is to provide a comprehensive overview of the rare bone
disorders domain and to enable researchers and clinicians
to analyse in a comparative manner the different perspec-
tives on their genetic and phenotypic descriptions. RBDO
is at the border between a domain ontology and an appli-
cation ontology. On one hand, it can be used for reasoning
tasks, similar to a domain ontology. On the other hand,
it can also be used to serve specific integration purposes,
subject to the underlying application. The current state of
RBDO integrates BDO/ISDS 2010 (the latest to date) and
Orphanet data May 2014.
Using RBDO, researchers will be able to answer queries,
such as: “What phenotypes describe a particular dis-
order and are common to all sources?” or to under-
stand similarities between disorders based on divergent
groupings (classifications) provided by the underlying
sources. As a remark, ’all sources’ refers in this con-
text to the sources used for integration by RBDO. From
a computational perspective, RBDO supports, among
other things, the creation of personalised views over the
domain knowledge (e.g., by choosing a particular source
or combining several sources), which can subsequently
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be used for automated consistency checking and reason-
ing (e.g., classifying disorders based on their phenotype
description). Conceptually, the model used by RBDO can
be applied in any biomedical domain that may take advan-
tage from the integration of various sources of knowledge,
however, our current focus is only on bone disorders.
Benefits of loosely integrated domain knowledge
views
The previous section has noted various differences
between the BDO/ISDS and Orphanet, including: (i) dif-
ferent taxonomical groupings; (ii) different ways of sub-
typing disorders; or (iii) different phenotypic descriptions.
Here we discuss the benefits of using a light and flexi-
ble taxonomic representation to incorporate the different
views on the domain knowledge, by maintaining both the
granularity, as well as provenance.
• Aggregated analysis: Traditionally, ontologies
externalise knowledge statements defined by an
underlying community. On the other hand, an
ontology that integrates the viewpoints of multiple
communities creating and publishing knowledge in
the same domain enables an aggregated analysis over
this domain knowledge. For example, a researcher is
able to understand and analyse the differences in
phenotype descriptions between BDO/ISDS and
Orphanet (in agreement or disagreement) or
complement missing descriptions in one source with
those defined by the other. Similarly, automated
classification or reasoning mechanisms can take
advantage of the multiple viewpoints definition of the
knowledge and give a higher weight or impact to
those statements that have been defined by both (or
several) sources as opposed to those defined by a
single source.
• Extensibility: Incorporating additional sources in a
model that targets integration implies the analysis of
the common and distinctive knowledge statements.
This is then followed by an enrichment of the
ontology with those statements that have not been
defined yet, or by adding the new source as
provenance to already existing statements. As an
example, we intend in the near future to incorporate
in RBDO also the classification and description of
bone dysplasias according to Spranger et al. [28]. This
differs, again, in various aspects, including the
grouping strategy or association with different
phenotypes and thus will provide yet another
perspective on the bone dysplasia knowledge.
• Backwards compatibility: By keeping track of the
provenance of all elementary knowledge statements,
one is able to re-create the original model – as
initially developed by a group / organisation – simply
by building a view over the ontology from the
perspective of the corresponding entity. For example,
the original BDO/ISDS classification can be
re-created by retaining from the current Rare Bone
Disorder Ontology only those concepts and relations
that were attributed to ISDS and OMIM. Such an
operation may be desirable if classification according
to a particular group / organisation is sought.
Integratingmultiple classifications and recording
the associated provenance
A typical ontology consists of a hierarchy and a set of
additional relations between its concepts. The hierar-
chy denotes, for example, the taxonomy of disorders,
e.g., Acrodysostosis is a sub-class of Acromelic
Dysplasias. On the other hand, the additional relation-
ships may be used to related these concepts to other con-
cepts introduced by the ontology, or to concepts defined
by other ontologies. For example, in the Bone Dysplasia
Ontology (BDO) we find Achondroplasia to be char-
acterised_by Macrocephaly (HP:0000256) and to have
associated_gene FGFR3.
The conceptual model we propose follows to a large
extent the same direction, but introduces two modelling
distinctions. First, we propose the use of the Simple
Knowledge Organisation System (SKOS) [23] to capture
the hierarchy of disorders published by different enti-
ties (e.g., BDO/ISDS and Orphanet) SKOS is a W3C
recommendation and has been widely used for build-
ing lightweight classifications. It provides an alternative
mechanism to rigid logical classifications and it enables
a straightforward publishing of the same knowledge as
Linked Data. Finally, it is conceptually easy to understand
also by non-experts. Second, we impose the documenta-
tion of the provenance of all concepts and relationships in
the ontology – in order to keep track of the originating
source. We shall discuss and exemplify these two aspects
in the remainder of this section.
The knowledge engineering process
In order to build RBDO, we first had to gain a deep
understanding of the similarities and differences between
BDO/ISDS and Orphanet. Consequently, with the help of
a bone dysplasia expert, we performed a manual com-
parative analysis of the two sources, which included: 1. a
manual alignment of the disorders and groups of disorders
(using a spreadsheet); 2. a manual inspection, followed by
an intersection of the genotype knowledge associated with
each disorder; and 3. a repetition of the previous step for
phenotype knowledge.
Figure 1 depicts the major RBDO concepts and their
associated relationships. These concepts have been
adapted from the generic concepts initially defined in
the Bone Dysplasia Ontology – i.e., Bone Disorder


















Figure 1 The upper-level structure of the Rare Bone Disorder Ontology.
Group, Bone Disorder and Gene – in addition to re-
using the knowledge captured by the Human Phenotype
Ontology via its top level concept HP:0000118 (Phe-
notypic abnormality). The relations between Bone
Disorder and Gene and Bone Disorder and
HP:0000118, respectively, are conceptually the same as
in BDO, i.e., a Bone Disorder has associated_gene any
Gene and Bone Disorder has associated_phenotype
any HP:0000118. A major difference to BDO is, how-
ever, the clear semantic distinction between group
membership and disorder sub-typing via the SKOS
vocabulary - discussed in detail later in the paper. Finally,
provenance is recorded using the Provenance Ontology
(PROV-O) [24], a World Wide Web Consortium recom-
mendation, at all levels, for example, when defining bone
disorders or associating a bone disorder with a gene.
It is important to note that our effort does not propose a
novel ontology mapping approach. The literature contains
a wealth of such solutions and we would refer the reader
to [29] for a comprehensive overview. We, instead, focus
on devising a conceptual mapping model for domain-
specific taxonomies, with the added value of provenance,
while the actual mapping process has been performed
manually by a domain expert. This model is comple-
mentary to the existing automatic mapping approaches
and provides an upper level scheme that can be used to
integrate the mapping results.
Modelling the taxonomy of bone disorders
In a typical ontology, the classification of disorders is
modelled using the class – sub class relationship. The
semantics of the sub-class relationship is one of specializa-
tion - for example, Mesomelic dysplasia Korean
type or Mesomelic dysplasia Savarirayan
type are subtypes of Mesomelic dysplasia. And
while most ontologies use it appropriately, some use it
with a different semantics, i.e., as a part-Of relationship,
to show the membership of a particular disorder to a
group – e.g., Acrodysostosis is a sub-class of – i.e.,
member of – Acromelic Dysplasias. Consequently,
the same relationship is used with two different connota-
tions, which does not capture accurately the semantics of
the domain knowledge.
A second aspect that requires consideration is the fact
that the same disorder can be classified into multiple
groups, which may occur either due to the ambiguity
introduced by the way in which the groups were formed,
or by taking into account the knowledge provided by
multiple sources. As an example in the first category,
the FGFR3 Chondrodysplasia Group, defined by
BDO/ISDS, collates bone disorders caused by a mutation
in FGFR3 – hence the grouping is performed on a genetic
basis. The Lacrimo-Auriculo-Dento-Digital
syndrome (LADD), a disorder known to be caused also
by a mutation in FGFR3, has however been placed in
the Polydactyly-Syndactyly-Triphalangism
Group in BDO/ISDS because of its clinical character-
istics. Similarly, an example in the second category is
the Holt-Oram syndrome: in BDO/ISDS the disor-
der is part of the Limb hypoplasia - reduction
defects Group, while in Orphanet it represents a sub-
type of the Heart-hand syndrome, which is classified
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under Dysostosis with limb anomaly as a
major feature.
An elegant solution to address both above men-
tioned aspects is adopting the Simple Knowledge Orga-
nization System (SKOS). As mentioned above, SKOS
enables the realisation of lightweight classifications via
concepts that are easily understandable also by non-
experts. For the purpose of our solution, two SKOS
entities are of interest: SKOS Collection and SKOS
Concept.
SKOS Concepts are the fundamental units of the
SKOS vocabulary and they denote units of thought, i.e.,
ideas, meanings, objects, events, which underpin most of
existing knowledge organizations systems. In our case,
Bone Disorders, Genes and Phenotypes act as
fundamental units of the ontology and of the domain (as
per Figure 1). SKOS Collections provide a natural
method to define meaningful groupings of concepts, such
as Bone Disorder Groups. The actual grouping is
realised by connecting a Collection to a Concept via
the skos:member relationship (see Figure 1). Hence, from
a general perspective Bone Disorder Groups are
SKOS Collections, Bone Disorders are SKOS
Concepts and Bone Disorder Groups have mul-
tiple Bone Disorder members. Moreover, in order
to build multi-level hierarchies, SKOS Collections
can, subsequently, be members of other SKOS
Collections, via the same skos:member relationship.
This is, for example, not possible if instead of using SKOS
Collections we would have used SKOS Concept
Schemes.
The advantage of using this modelling approach is
that it enables us to place bone disorders into multiple
groups, as well as to assign a clear semantics to group
membership, and to aggregating groups of bone dis-
orders and bone disorders, respectively, into the same
group. The example above has already exhibited the
multi-group membership within a taxonomy or across
taxonomies. An example of multi-group membership
with a mixture of both groups and disorders is the case of
the Orphanet Dysostosis group (Orphanet:364559).
Dysostosis has as members Dysostosis with
predominant craniofacial involvement
(Orphanet:93453) and Patellar dysostosis (Orp-
hanet:93455), which are groups on their own, but also
Congenital pseudoarthrosis of clavicle
(Orphanet:66630), which is a disorder.
So far, we have addressed the issue of modelling
groups of bone disorders. The second aspect relevant
for the hierarchy is the disorder sub-typing, as per the
previous example about Mesomelic dysplasia:
Korean type, Kantaputra type, Savarirayan type. Sim-
ilar to the grouping of disorders, SKOS provides a
way to model this aspect using a clear semantics via
the skos:broaderTransitive and skos:narrowerTransitive
relationships – i.e., a Bone Disorder can be
skos:broaderTransitive or skos:narrowerTransitive with
respect to another Bone Disorder (see Figure 1).
In practice, both relationships denote two elements:
the broader / narrower association between Bone
Disorders, e.g., Mesomelic dysplasia is broader
conceptually than Mesomelic dysplasia, Korean
type, as well as the transitivity aspect which ensures a
natural hierarchy of disorders. An example of this order is
presented in Figure 2: Polydactyly (Orphanet:2913)
is broader than Preaxial polydactyly of fin-
gers (Orphanet:294939), which in turn is broader
than Polydactyly of a triphalangeal thumb
(Orphanet:93336). Transitivity hence enforces Poly-
dactyly (Orphanet:2913) to be, due to the
existing broader relationships, also broader than
Polydactyly of a triphalangeal thumb
(Orphanet: 93336).
In addition to the hierarchical structure, the Rare
Bone Disorders Ontology defines the relationships
required to describe disorders by means of their under-
lying genetic and phenotypic characteristics. These
relationships are associated_gene that connects a
Bone Disorder to a Gene (e.g., Achondroplasia
associated_gene FGFR3) and associated_phenotype
that connects a Bone Disorder to Phenotypic
abnormality (HP:0000118) – e.g., Achondroplasia
associated_phenotype Macrocephaly (HP:0000256).




Preaxial polydactyly of 
ORPHA: 93336




Figure 2 Example of disorder sub-typing via skos:broaderTransitive relations. Polydactly is broader than Preaxial polydactyly of
fingers, which is broader than Polydactyly of a triphalangeal thumb. The use of skos:broaderTransitive in this triumvirate implies
that Polydactyly is hence broader than Polydactyly of a triphalangeal thumb.
Groza et al. Journal of Biomedical Semantics  (2015) 6:21 Page 8 of 15
extra knowledge about Bone Disorders, such as
the mode_of_inheritance relation, which relates a Bone
Disorder to Mode of Inheritance (HP:0000005).
All associations between Bone Disorders and their
related concepts are modelled as OWL restrictions.
In conclusion, using the grouping and broader/narrower
capabilities provided by SKOS, we are able to capture the
entire knowledge encoded by both the ISDS Nosology
(and hence BDO), as well as the Orphanet classification. A
complete overview of the definitions and axioms defined
by this new ontology are provided later in the paper.
Recording provenance
Our approach records provenance at all granularity lev-
els in the ontology – i.e., both when defining concepts,
as well as when associating them via relationships. We
believe that tracking provenance is currently a key aspect
in domain-specific knowledge engineering and in particu-
lar in domains where the knowledge is not fully matured.
Provenance offers a clear perspective on the origins of the
diverse knowledge units, in addition to enabling a com-
parative view over those knowledge units that have been
modelled by multiple sources. By embedding it within the
definition of the ontological concepts, we can, by default,
capture the entity that defines both the ontological con-
cepts, as well as the diverse relationships that characterise
them. We will discuss a concrete example further down in
this section.
In order to capture provenance in RBOD, we adopted
another well-known W3C recommendation – the Prove-
nance Ontology (PROV-O). PROV-O provides the set
of classes, properties and restrictions required to rep-
resent and share provenance. It consists of ten classes
describing entities, agents and activities and a wide range
of properties that cover aspects such as provenience,
authorship, temporality, influence or roles – all in the
context of provenance. For example, using PROV-O, one
is able to specify the primary source of an information
(prov:hadPrimarySource), to whom is the information
attributed (prov:wasAttributedTo) or where was it derived
from (prov:wasDerivedFrom).
Figure 3 depicts our ontology enriched with provenance.
Using this model, one can add provenance to both entities
defined in the ontology, as well as relationships created
between these entities. More concretely, provenance is
captured for:
• Bone Disorder Groups – e.g., FGFR3
Chondrodysplasia Group
prov:wasAttributedTo ISDS
• a particular Bone Disorder as part of its classification
































Figure 3 The upper-level structure of RBDO enriched with provenance information. As a note, the PROV: Entity concept is duplicated in the
figure for readability purposes.
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Achondroplasia prov:wasAttributedTo ISDS,
Orphanet




• broader / narrower relationships – e.g.,
Rubinstein-Taybi syndrome (Orphanet:783)
skos:narrowerTransitive Rubinstein-Taybi
syndrome due to 16p13.3
microdeletion (Orphanet:353281); statement
prov:wasAttributedTo Orphanet
• the association between a Bone Disorder and a




• the association between a Bone Disorder and a gene
– e.g., Achondroplasia associated_gene FGFR3;
statement prov:wasAttributedTo ISDS, Orphanet
All these aspects are depicted in an example in Figure 4,
using Spondyloepimetaphyseal dysplasia Ma-
roteaux type, its placement in BDO/ISDS andOrphanet
and some of its associated knowledge.
Implementation & availability
The Rare Bone Disorder Ontology (RBDO) aims to capture
the domain knowledge in a computer-processable way and
thus we opted for using a logical formalism to encode the
relationships between the concepts. The resulting ontology
class axioms not only encode the conceptual real-world
knowledge (e.g., Achondoplasia has associated_gene
FGFR3 and associated_phenotype Hydrocephalus
(HP:0000238) or Lumbar hyperlordosis (HP:000
2938)), but also enable users (and applications) to perform
reasoning on patient instance data. The actual formal-
ism we have used is the RL profile of the Web Ontology
Language (OWL) 2 [30].
OWL 2 RL enables applications to perform scalable
reasoning while at the same time maintaining most
of the language’s expressiveness. The profile has been
designed to cater for applications that allow a trade-off
between the full expressivity of OWL 2 and efficient
inference, since OWL 2 RL reasoning systems can be
implemented using typical rule-based reasoning engines.
Finally, this profile enables the use cases targeted by our
ontology, i.e., consistency checking, class expression sub-
sumption or conjunctive query answering, in a scalable
and reliable way. We will use the Manchester syntax, a
user-friendly syntax for OWL 2, to present the formal
representation of the RBDO examples throughout this
section.
Table 1 denotes the fact sheet of RBDO. The ontol-
ogy defines two relationships and three own classes,
the rest being re-used from Human Phenotype Ontol-
ogy, SKOS and PROV-0. The two relationships (associ-
ated_gene and associated_phenotype, both defined using
the Manchester syntax, in the listing below) enable
us to relate bone disorders to genes and to phe-
notypes, respectively – the latter defined by HPO
concepts.
Figure 4 Excerpt from RBDO showing the placement, relationships and information attached to Spondyloepimetaphyseal dysplasia
Maroteaux type. Dark ovals represent concepts in the ontology, and white ovals represent the original source of the concept or relationship.
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Table 1 The rare bone disorder ontology fact sheet
Namespace http://purl.org/skeletome/rbdo#
Prefix RBDO
Scope Bone disorders, genes, phenotypic characteristics in human
Format OWL 2 RL
High-level classes defined Bone Disorder, Gene, Bone Disorder Group
Relationships defined associated_gene, associated_phenotype, mode_of_inheritance
Provenance entities defined ISDS, OMIM, Orphanet
Number of bone disorders 1,146
Number of bone disorder groups 51
Number of genes 383
Total number of classes 1,586
Total number of phenotypes reused 2,750
Dependencies HPO, SKOS, PROV-O










The central concept of the ontology is the Bone
Disorder class (see Figure 1 and listing below), which
is defined as an entity characterised by a mode of inheri-
tance (re-used from HPO) and by a series of associations
with specific genes and phenotypes. Bone Disorders
can be grouped into Bone Disorder Groups using
the skos:member relation as shown in the previous section
and can be associated with genes and phenotypes as per
the above corresponding relation definitions. It is worth
noting that the ontology defines Bone Disorders via
a novel artefact introduced in OWL 2 – namely, punning
– which allows an entity to be defined both as a class of
concepts and as an instance of a particular concept at the
same time. This was required in order to be able to accom-
modate the SKOS taxonomical structure, since a SKOS
Concept is a class on its own, while bone disorders rep-
resent instances of SKOS Concepts. More details are
shown in the example presented later in the section.
Class: Bone_Disorder
Types: SKOS:Concept
SubClassOf: mode_of_inheritance some HP:HP_
0000005
SubClassOf: associated_gene some Gene
SubClassOf: associated_phenotype some HP:
HP_0000118
A key aspect of RBDO is the presence of provenance
embedded within the logical definitions of the concepts.
This is, in principle, possible due to another technical
artefact introduced by OWL 2, which enables the defini-
tion of annotation assertions on class axioms and property
restrictions. More concretely, as we will see in the next
example, every class definition (and hence association
with genes and phenotypes) or group membership defi-
nition is annotated with a provenance statement, which
enables us, at any time, to track its original creator and
eventually to create a specific provenance-driven view
over the knowledge in the ontology.
In order to have a better understanding of the logi-
cal descriptions introduced in RBDO we detail below the
























Firstly, let us note the definition of the Spondylo-epi
(-meta)physeal dysplasias (BDG0000035) and
TRPV4 Group (BDG0000038) bone disorder groups,
as shown in the listings above. We can observe that
the former has been defined by both ISDS and
Orphanet, while the second is present only in ISDS. Fur-
thermore, Spondyloepimetaphyseal dysplasia
Maroteaux type (BD0000189) is listed as a mem-
ber of both groups (see skos:member BD0000189 in
the definition of each group). The prov:wasAttributedTo
statements in the listings denote the use of annota-
tion assertions to assign specific provenance to each
group membership. The first statement captures the
provenance of the group membership relation with
Spondylo-epi(-meta)physeal dysplasias and
assigns it to Orphanet, while the second has the same





















The actual definition of the disorder is presented in the
listing above. As a remark, for brevity, some of the axioms
have been left out from this listing. Here, Spondyloe-
pimetaphyseal dysplasia Maroteaux type is
defined as a bone disorder belonging to both ISDS and
Orphanet and which may be associated with Genu
Valgum (HP:0002857) and with the TRPV4 gene













Finally, the same mechanism for annotating the group
membership provenance is used to annotate the class
axioms and enforces the bone disorder to be defined
in the context of the association with some phenotypes
and genes. The prov:wasAttributeTo statements using in
the listings above capture the provenance of the associ-
ation with Genu Valgum (HP:0002857) and assigns it
to OMIM, as well as the provenance of the underlying
genetic mechanism – i.e., the association with the TRPV4
gene (GENE0000100) and assigns it to both ISDS and
Orphanet.
Publishing bone dysplasia Linked Data
As shown and discussed in the previous section, the Rare
Bone Disorders Ontology has been made available in
OWL 2 RL format in order to support a smooth transition
to a specific entity-oriented view (i.e., BDO or Orphanet).
This would then enable direct consistency checking and
classification based on the current ontology axioms. The
same knowledge, however, can also be published in a
lighter format – a format focused on easy integration and
query. Consequently, we have also transformed the ontol-
ogy into a query and integration endpoint using a Linked
Data approach.
The Linked Data initiative [31] has initially emerged
from the need of making data trapped within legacy sys-
tems openly available on theWeb for reuse and integration
purposes. The proposed publishing process relies on four
simple principles:
• Use unique identifiers (URIs) to denote
entities/concepts/etc
• Use retrievable Web identifiers to enable both
humans and machines to look up and access the
entities corresponding to these identifiers
• Use structured formats (i.e., machine processable) to
represent the data – or more precisely RDF –
Resource Description Framework [CITE]
• Include links to other entities
The initiative has proved to be very successful, and has
led to a massive growth in Linked Data datasets now avail-
able in RDF format on the Web – over 300 datasets of
which around 20% are only in Life Sciences and include
among others UniProt [32], NCBI Gene, KEGG Path-
way, OMIM or Reactome [33]. The de facto language
used to access and integrate this data is SPARQL (Simple
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Protocol and RDF Query Language) [34], which provides
a set of specifications for querying their underlying graph
structure.
The literature consists of several good examples of using
integrated data to achieve particular goals in specific
contexts. For example, Taboada et al. [35] have inte-
grated SNOMED CT, OMIM and HPO and a patient
clinical dataset in order to bridge the gap between
domain specific phenotype descriptions and clinical data
in the context of Cerebrotendinous Xanthomatosis. Con-
sequently, they were able to successfully infer bidirec-
tional phenotype-genotype relations in their domain of
interest – e.g., “What are the genetic variants that have
been associated with a combination of traits?”. Simi-
larly Zhu et al. used Linked Data to perform drug
data normalisation in the Pharmacogenomics Knowledge
Base (PharmGKB) [36], while Kiefer et al. [37] mined
genotype-phenotype associations in Gene Wiki Plus and
OMIM, with a focus on commonly occurring chronic
diseases.
In order to support this initiative and enable future
integration of the bone disorders knowledge, we have pub-
lished RBDO as a SPARQL Endpoint – available at: http://
bio-lark.org/se_skeldys.html. Furthermore, we have also
built a simple query interface to provide researchers and
clinicians with the opportunity of exploring it – as shown
in Figure 5. The interface uses a set of customisable
templates that guide the user in building the desired
queries. Currently, it offers a direct access to answer-
ing questions, such as “Bone Disorders associated with
a given GENE” or “Bone Disorders associated with a
given PHENOTYPE”. For example, given the first type of
query, a researcher needs only to select from the exist-
ing gene list the desired one (as depicted in Figure 6).
Figure 5 Main user interface of the Rare bone disorders SPARQL Endpoint. Users can select an existing query template to run, or write their own
SPARQL queries.
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Figure 6 Example of query via autocompletion: “All bone disorders
associated with a chosen GENE”.
The interface then translates it into SPARQL and exe-
cutes the query. The results are provided in a tabu-
lated form (see Figure 7) and include the provenance
of the disorder - gene association and a rapid filtering
functionality, in the case in which a particular disorder is
sought.
The Bone Disorders SPARQL Endpoint is the first ini-
tiative of this kind in the rare bone disorder domain and
represents only the first step in our integration plan. Next
steps include the integration of this knowledge with other
datasets of direct interest, like KEGG Pathway (defining
pathway – gene – disorder associations), Cell Cycle Ontol-
ogy [38] (describing the cell cycle process inclusive of GO
annotations) and Gene Ontology (defining among others
biological andmolecular functions). Consequently, the list
of query templates will be enriched with new elements to
enable an exploration of phenotype - pathway associations
or disorder - phenotype - biological functions associa-
tions. Finally, to provide an even more comprehensive
view over the domain, we intend to integrate bone dys-
plasia mouse genotype and phenotype knowledge from
KEGG,MouseGenome Informatics, theMammalian Phe-
notype ontology [39] and the MP – HPO alignments,
which will enable the unique opportunity of executing
cross-species genotype and phenotype queries.
Discussion
In this section, we discuss some of the challenges encoun-
tered in building RBDO, as well as some of its current
limitations.
RBDO, as any other domain ontology, relies on the inter-
pretation of the domain knowledge, interpretation which
is then captured into the ontological definitions. In our
case, this raised challenges when performing the manual
mapping process, and especially when deciding the nature
of some of the concepts in Orphanet – i.e., groups vs.
non-groups. Here, the decision has been taken subject to
the children of the concept under scrutiny. If the children
represented particular types of the same disorder (see the
Mesomelic dysplasia examples earlier in the paper),
the concept has been defined as a Bone Disorder, and
its children were sub-typed using skos:broaderTransitive
relations. If, however, the children were a mixture of
possible groups and disorders well-defined (using also
BDO/ISDS as background knowledge), then the concept
was defined as a Bone Disorder Group.
The goal of RBDO is to provide the scaffolding required
to capture knowledge defined by several sources. Since
Figure 7 Example of results returned for the query “All bone disorders associated with FGFR3”.
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this knowledge is not necessarily aligned (as in our use
case), we may encounter logical conflicts when trying to
consolidate it. For example, one source may define a bone
disorder to be associated with a particular phenotype,
which on its own, may be disjoint with another phenotype
that is associated to the same disorder by another source.
Currently, RBDO does not contain such conflicts because
of the lack of a finer-grained definition of the disorder -
phenotype associations and of the underlying phenotypic
concepts. However, one of the major advantages of RBDO
is that it is able to deal with this aspect, simply by allowing
conflicting information to exist and recording its prove-
nance. We believe that such information is valuable and
should be maintained because it allows researchers to get
a better understanding of the rationale behind the current
classification of disorders. If logical consistency is sought,
this can be achieved either by filtering the RBDO knowl-
edge according to a single source, or bymanually resolving
existing conflicts when integrating multiple sources.
A final remark is worth mentioning about the sustain-
ability and evolution of RBDO. The initial Bone Dyspla-
sia Ontology has been published and used to generate
the SKELETOME knowledge base – a community-driven
platform for knowledge curation in the skeletal dyspla-
sia domain. This platform implements an editorial pro-
cess to describe and enrich knowledge around bone dys-
plasias and enables a continuous expert-based evolution
of the underlying ontology. We plan in the near future to
expand the SKELETOME knowledge based to incorporate
RBDO, including the functionality required to add addi-
tional sources and to discuss conflicting knowledge. All
interested researchers and clinicians will have access to
SKELETOME and will be able to contribute to the cura-
tion and evolution of this rare bone disorders source of
knowledge.
Conclusions
In this paper, we have presented our effort in building and
publishing an innovative model for capturing domain spe-
cific knowledge from multiple information sources using
the rare bone disorders domain as our use case. We have
shown how multiple, diverging taxonomies can be ele-
gantly integrated using SKOS structures, as well as how to
record provenance at all ontology definition levels – rang-
ing from group membership, disorder sub-typing or dis-
order characterisation. The model has been implemented
as a OWL2 RL ontology, to enable logical formalisation of
the knowledge. Furthermore, the same knowledge has also
been published in a lightweight format using Linked Data,
to support immediate integration and querying.
A major limitation of our current work is the restricted
range of queries that can be executed on the published
SPARQL endpoint – in principle, this supports only basic
interrogations on the association of bone disorders to
phenotype and genotype. Our future efforts will, however,
focus on continuously curating and expanding the knowl-
edge in the rare bone disorders domain by integrating
additional information sources including both human and
cross-species data. This will enrich significantly the types
of possible queries and will enable us to develop targeted
knowledge discovery and exploration tools.
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